Literature DB >> 33388235

Clinical and biochemical footprints of inherited metabolic diseases. IV. Metabolic cardiovascular disease.

Carlos R Ferreira1, Nenad Blau2.   

Abstract

Inherited metabolic diseases account for 15-20% of all cases of pediatric cardiomyopathy, with a high mortality of 15-47%. Metabolic diseases can also commonly be associated with other types of cardiovascular involvement such as arrhythmias, valvulopathy or vasculopathy. We reviewed and updated the list of known metabolic etiologies associated with cardiovascular involvement, and found 246 relevant inborn errors of metabolism. This represents the fourth of a series of articles attempting to create and maintain a comprehensive list of clinical and metabolic differential diagnoses according to system involvement. Published by Elsevier Inc.

Entities:  

Keywords:  Dilated Cardiomyopathy; Hypertrophic Cardiomyopathy; Inborn Error Of Metabolism; Left-Ventricular Non-Compaction; Metabolic cardiomyopathy; Restrictive Cardiomyopathy

Mesh:

Year:  2020        PMID: 33388235      PMCID: PMC7867625          DOI: 10.1016/j.ymgme.2020.12.290

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  55 in total

Review 1.  Gaucher disease type 3c: New patients with unique presentations and review of the literature.

Authors:  Alina Kurolap; Mireia Del Toro; Ronen Spiegel; Ariel Gutstein; Gideon Shafir; Ian J Cohen; José A Barrabés; Hagit Baris Feldman
Journal:  Mol Genet Metab       Date:  2019-05-21       Impact factor: 4.797

2.  Cardiac arrest secondary to long QT(C )in a child with propionic acidemia.

Authors:  Elisabeth Jameson; John Walter
Journal:  Pediatr Cardiol       Date:  2007-12-05       Impact factor: 1.655

Review 3.  Cardiac metabolism in heart failure: implications beyond ATP production.

Authors:  Torsten Doenst; Tien Dung Nguyen; E Dale Abel
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

4.  Pompe's disease presenting as hypertrophic myocardiopathy with Wolff-Parkinson-White syndrome.

Authors:  B H Bulkley; G M Hutchins
Journal:  Am Heart J       Date:  1978-08       Impact factor: 4.749

5.  Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history.

Authors:  Ross T Murphy; Jens Mogensen; Kate McGarry; Ajay Bahl; Alison Evans; Eyman Osman; Petros Syrris; Grainne Gorman; Michael Farrell; Janice L Holton; Michael G Hanna; Sian Hughes; Perry M Elliott; Calum A Macrae; William J McKenna
Journal:  J Am Coll Cardiol       Date:  2005-03-15       Impact factor: 24.094

Review 6.  Infant with cardiomyopathy: When to suspect inborn errors of metabolism?

Authors:  Stephanie L Byers; Can Ficicioglu
Journal:  World J Cardiol       Date:  2014-11-26

7.  Wolff-Parkinson-White syndrome in Patients With MELAS.

Authors:  Douglas M Sproule; Petra Kaufmann; Kristen Engelstad; Thomas J Starc; Allan J Hordof; Darryl C De Vivo
Journal:  Arch Neurol       Date:  2007-11

8.  The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses.

Authors:  Vlasta Fesslová; Paola Corti; Giovanna Sersale; Attilio Rovelli; Pierluigi Russo; Savina Mannarino; Gianfranco Butera; Rossella Parini
Journal:  Cardiol Young       Date:  2009-02-06       Impact factor: 1.093

9.  Natural history of Danon disease.

Authors:  Dana Boucek; Jean Jirikowic; Matthew Taylor
Journal:  Genet Med       Date:  2011-06       Impact factor: 8.822

Review 10.  Maturation of Cardiac Energy Metabolism During Perinatal Development.

Authors:  Jérôme Piquereau; Renée Ventura-Clapier
Journal:  Front Physiol       Date:  2018-07-19       Impact factor: 4.566

View more
  2 in total

Review 1.  Clinical and biochemical footprints of inherited metabolic diseases. VIII. Neoplasias.

Authors:  Teodoro Jerves; Nenad Blau; Carlos R Ferreira
Journal:  Mol Genet Metab       Date:  2022-03-28       Impact factor: 4.204

Review 2.  Clinical and biochemical footprints of inherited metabolic diseases. VI. Metabolic dermatoses.

Authors:  Carlos R Ferreira; Diego Martinelli; Nenad Blau
Journal:  Mol Genet Metab       Date:  2021-07-21       Impact factor: 4.204

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.